AZENTA INC (AZTA) Fundamental Analysis & Valuation
NASDAQ:AZTA • US1143401024
Current stock price
21.42 USD
+0.05 (+0.23%)
At close:
21.42 USD
0 (0%)
After Hours:
This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AZTA Profitability Analysis
1.1 Basic Checks
- AZTA had positive earnings in the past year.
- AZTA had a positive operating cash flow in the past year.
- In multiple years AZTA reported negative net income over the last 5 years.
- Of the past 5 years AZTA 4 years had a positive operating cash flow.
1.2 Ratios
- AZTA has a Return On Assets of -2.79%. This is comparable to the rest of the industry: AZTA outperforms 56.14% of its industry peers.
- AZTA's Return On Equity of -3.37% is in line compared to the rest of the industry. AZTA outperforms 59.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 44.59%, AZTA is in line with its industry, outperforming 42.11% of the companies in the same industry.
- AZTA's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. AZTA Health Analysis
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AZTA has been increased compared to 1 year ago.
- AZTA has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for AZTA has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.15 indicates that AZTA is not in any danger for bankruptcy at the moment.
- AZTA has a Altman-Z score of 3.15. This is in the better half of the industry: AZTA outperforms 70.18% of its industry peers.
- AZTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.15 |
ROIC/WACCN/A
WACC11.01%
2.3 Liquidity
- A Current Ratio of 2.92 indicates that AZTA has no problem at all paying its short term obligations.
- AZTA has a Current ratio of 2.92. This is comparable to the rest of the industry: AZTA outperforms 54.39% of its industry peers.
- A Quick Ratio of 2.61 indicates that AZTA has no problem at all paying its short term obligations.
- The Quick ratio of AZTA (2.61) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 |
3. AZTA Growth Analysis
3.1 Past
- AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.89%, which is quite good.
- AZTA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.04% yearly.
- The Revenue has decreased by -8.40% in the past year.
- AZTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.86% yearly.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
3.2 Future
- The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y51.54%
EPS Next 2Y41.77%
EPS Next 3Y34.58%
EPS Next 5Y27.49%
Revenue Next Year4.66%
Revenue Next 2Y5.04%
Revenue Next 3Y5.55%
Revenue Next 5Y5.37%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. AZTA Valuation Analysis
4.1 Price/Earnings Ratio
- AZTA is valuated quite expensively with a Price/Earnings ratio of 39.67.
- Based on the Price/Earnings ratio, AZTA is valued a bit cheaper than the industry average as 61.40% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of AZTA to the average of the S&P500 Index (25.70), we can say AZTA is valued expensively.
- Based on the Price/Forward Earnings ratio of 20.11, the valuation of AZTA can be described as rather expensive.
- 77.19% of the companies in the same industry are more expensive than AZTA, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 23.84. AZTA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.67 | ||
| Fwd PE | 20.11 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZTA indicates a rather cheap valuation: AZTA is cheaper than 85.96% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, AZTA is valued a bit cheaper than the industry average as 64.91% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.9 | ||
| EV/EBITDA | 12.63 |
4.3 Compensation for Growth
- AZTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as AZTA's earnings are expected to grow with 34.58% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y41.77%
EPS Next 3Y34.58%
5. AZTA Dividend Analysis
5.1 Amount
- No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AZTA Fundamentals: All Metrics, Ratios and Statistics
21.42
+0.05 (+0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners115.54%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap986.61M
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target38.47 (79.6%)
Short Float %11.12%
Short Ratio6.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-4.35%
PT rev (3m)-2.22%
EPS NQ rev (1m)4.85%
EPS NQ rev (3m)-23.39%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.67 | ||
| Fwd PE | 20.11 | ||
| P/S | 1.66 | ||
| P/FCF | 31.9 | ||
| P/OCF | 15.81 | ||
| P/B | 0.58 | ||
| P/tB | 1.08 | ||
| EV/EBITDA | 12.63 |
EPS(TTM)0.54
EY2.52%
EPS(NY)1.07
Fwd EY4.97%
FCF(TTM)0.67
FCFY3.14%
OCF(TTM)1.35
OCFY6.32%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.77
PEG (5Y)N/A
Graham Number21.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% | ||
| FCFM | 5.2% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 55.45% | ||
| Cap/Sales | 5.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 156.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3.15 |
F-Score5
WACC11.01%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y51.54%
EPS Next 2Y41.77%
EPS Next 3Y34.58%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year4.66%
Revenue Next 2Y5.04%
Revenue Next 3Y5.55%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year495.06%
EBIT Next 3Y107.17%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 5 / 10 to AZTA.
What is the valuation status of AZENTA INC (AZTA) stock?
ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
Can you provide the financial health for AZTA stock?
The financial health rating of AZENTA INC (AZTA) is 8 / 10.
How sustainable is the dividend of AZENTA INC (AZTA) stock?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.